357 related articles for article (PubMed ID: 19389828)
21. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
22. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.
Kanda A; Noda K; Saito W; Ishida S
Diabetologia; 2012 Nov; 55(11):3104-13. PubMed ID: 22930161
[TBL] [Abstract][Full Text] [Related]
23. [Experimental study of (Pro)renin receptor siRNA inhibiting retinal neovascularization].
Cheng J; Dong XG
Zhonghua Yan Ke Za Zhi; 2011 Mar; 47(3):202-9. PubMed ID: 21609620
[TBL] [Abstract][Full Text] [Related]
24. (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells.
Sakoda M; Ichihara A; Kaneshiro Y; Takemitsu T; Nakazato Y; Nabi AH; Nakagawa T; Suzuki F; Inagami T; Itoh H
Hypertens Res; 2007 Nov; 30(11):1139-46. PubMed ID: 18250563
[TBL] [Abstract][Full Text] [Related]
25. Role of angiotensin II in retinal leukostasis in the diabetic rat.
Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG
Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509
[TBL] [Abstract][Full Text] [Related]
26. Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy.
Kanda A; Ishida S
Inflamm Regen; 2016; 36():22. PubMed ID: 29259695
[TBL] [Abstract][Full Text] [Related]
27. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
[TBL] [Abstract][Full Text] [Related]
28. Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cells.
Haque R; Iuvone PM; He L; Hur EH; Chung Choi KS; Park D; Farrell AN; Ngo A; Gokhale S; Aseem M; Kumar B
J Recept Signal Transduct Res; 2017 Dec; 37(6):560-568. PubMed ID: 28840773
[TBL] [Abstract][Full Text] [Related]
29. Prorenin and the (pro)renin receptor: recent advances and implications for retinal development and disease.
Wilkinson-Berka JL; Miller AG; Binger KJ
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):69-76. PubMed ID: 21099684
[TBL] [Abstract][Full Text] [Related]
30. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
[TBL] [Abstract][Full Text] [Related]
31. Pathologic roles of prorenin and (pro)renin receptor in the eye.
Satofuka S; Ichihara A; Nagai N; Tsubota K; Itoh H; Ishida S
Front Biosci; 2008 May; 13():3884-95. PubMed ID: 18508482
[TBL] [Abstract][Full Text] [Related]
32. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
[TBL] [Abstract][Full Text] [Related]
33. Critical roles of (pro)renin receptor-bound prorenin in diabetes and hypertension: sallies into therapeutic approach.
Ichihara A; Itoh H; Inagami T
J Am Soc Hypertens; 2008; 2(1):15-9. PubMed ID: 20409880
[TBL] [Abstract][Full Text] [Related]
34. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.
Takahashi H; Ichihara A; Kaneshiro Y; Inomata K; Sakoda M; Takemitsu T; Nishiyama A; Itoh H
J Am Soc Nephrol; 2007 Jul; 18(7):2054-61. PubMed ID: 17538189
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression.
He M; Zhang L; Shao Y; Xue H; Zhou L; Wang XF; Yu C; Yao T; Lu LM
Mol Cell Endocrinol; 2010 Feb; 315(1-2):188-94. PubMed ID: 19879325
[TBL] [Abstract][Full Text] [Related]
36. (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation.
Matavelli LC; Huang J; Siragy HM
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):277-82. PubMed ID: 19769609
[TBL] [Abstract][Full Text] [Related]
37. Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity.
Siragy HM; Huang J
Exp Physiol; 2008 May; 93(5):709-14. PubMed ID: 18192338
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells.
Haque R; Hur EH; Farrell AN; Iuvone PM; Howell JC
Mol Vis; 2015; 21():224-35. PubMed ID: 25802486
[TBL] [Abstract][Full Text] [Related]
39. The (pro)renin receptor: a new addition to the renin-angiotensin system?
Batenburg WW; Jan Danser AH
Eur J Pharmacol; 2008 May; 585(2-3):320-4. PubMed ID: 18417113
[TBL] [Abstract][Full Text] [Related]
40. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
